Information Hub
Access guidance, webcasts and publications with commentaries using the ABS Information Hub. Search by classification or using keywords.
To view the webcasts from previous ABS Conferences, events and webinars you must be an ABS member and be logged in using your membership username and password.
-
desktop_windows
Targeted axillary dissection in low volume nodal disease at diagnosis: UK practice survey (Tadpole)
Miss Katherine Fairhurst | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
desktop_windowsWebcast desktop_windows -
desktop_windows
Mr Baek Kim | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast Cancer Treatment
Keywords: Local recurrence Trials
desktop_windowsWebcast desktop_windows -
menu_book
MonarchE is an open-label, randomised, phase 3 trial which recruited high risk hormone receptor positive, HER2 receptor negative, node-positive breast cancer patients (n=5637). Patients were randomise...
Prof Stephen R D Johnston, MD et al | The Lancet Oncology
06.12.2022 | Added: 06.12.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Adjuvant treatment Endocrine therapy Trials
menu_bookPublication menu_book -
menu_book
The AMAROS trial evaluated axillary lymph node dissection (ALND; n=744) vs. axillary radiotherapy (ART; n=681) in patients with cT1-2 breast cancer with positive sentinel lymph node biopsy (SLNB). The...
Sanne A.L Bartels,MD,Phd,MSc et al | Journal of Clinical Oncology
16.11.2022 | Added: 16.11.2022
Classifications: Breast & Oncoplastic Surgery
Keywords: Axilla Sentinel Lymph Node Biopsy/ SLNB Trials Radiotherapy
menu_bookPublication menu_book -
menu_book
Targeted axillary dissection (TAD) involves targeted lymph node biopsy and SLNB. SenTa study is a prospective registry study conducted across 50 centres which aims to investigate the feasibility and a...
Sherko Kuemmel et al | National Library of Medicine
01.11.2022 | Added: 01.11.2022
Classifications: Breast & Oncoplastic Surgery
menu_bookPublication menu_book -
menu_book
This prospective multicentre cohort study aimed to determine surgical decision-making in the breast and axilla, as well as pathological complete response (pCR) rate in patients undergoing neoadjuvant ...
Hiba Fatayer et al | British Journal of Surgery
09.09.2022 | Added: 09.09.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT Early Breast Cancer Trials
menu_bookPublication menu_book -
menu_book
This randomised controlled trial evaluated whether a single bolus dose of 1.2g intravenous Augmentin reduced wound infection at 30 days after breast cancer surgery. 438 patients received prophylactic ...
Sheila Stallard et al | British Journal of Surgery
06.09.2022 | Added: 06.09.2022
Classifications: Breast & Oncoplastic Surgery
Keywords: Antibiotic Prophylaxis Trials Breast Surgery
menu_bookPublication menu_book -
menu_book
This study aimed to determine potential association between postoperative complications and survival in breast cancer patients as postoperative complications may activate prometastatic pathways. Patie...
Jana de Boniface et al | British Journal of Surgery
05.08.2022 | Added: 05.08.2022
Classifications: Breast & Oncoplastic Surgery
Keywords: Breast Surgery Complications Trials
menu_bookPublication menu_book -
desktop_windows
Kate Harvey | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Breast & Oncoplastic Surgery
Keywords: Prepectoral implant based breast reconstruction Breast Reconstruction Patients Trials
desktop_windowsWebcast desktop_windows -
desktop_windows
Are RCT leading or misleading us?
David Dodwell | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Other
desktop_windowsWebcast desktop_windows -
desktop_windows
James Lind Alliance Priority Setting Partnership – Setting research priorities for breast surgery
Stuart McIntosh | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Other
desktop_windowsWebcast desktop_windows -
desktop_windows
Iain MacPherson | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT Trials
desktop_windowsWebcast desktop_windows -
menu_book
The Pre-bra study has recently been published by Kate Harvey et al in the BJS. Consecutive patients electing to undergo immediate PPBR at participating UK centres between July 2019 and December 2020 w...
Kate L Harvey et al | National Library of Medicine
16.05.2022 | Added: 16.05.2022
Classifications: Breast & Oncoplastic Surgery
Keywords: Prepectoral implant based breast reconstruction Trials
menu_bookPublication menu_book -
menu_book
James Lind Alliance Priority Setting Partnership: Breast Cancer Surgery Research
In 2022 the ABS completed a priority setting partnership exercise with the James Lind Alliance to identify the Top 10 research priorities in breast cancer surgery
James Lind Alliance Priority Setting Partnership: Breast Cancer Surgery Research | Association of Breast Surgery
01.05.2022 | Added: 01.05.2022
Classifications: Breast & Oncoplastic Surgery
Keywords: Breast Surgery Trials Research
menu_bookPublication menu_book -
desktop_windows
desktop_windowsWebcast desktop_windows
-
menu_book
This national practice questionnaire (NPQ) was designed to establish the current practice of UK breast multidisciplinary teams (MDTs) regarding breast cancer locoregional recurrence (LRR) management. ...
Jenna L Morgan | National Library of Medicine
04.04.2022 | Added: 04.04.2022
Classifications: Breast Cancer Treatment
Keywords: Local recurrence Trials
menu_bookPublication menu_book -
menu_book
This EBCTCG meta-analysis investigated whether pre-menopausal women treated with ovarian suppression benefited from aromatase inhibitors (AIs). Meta-analysis was performed from individual patient data...
n/a | National Library of Medicine
23.03.2022 | Added: 23.03.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
menu_bookPublication menu_book -
menu_book
This pooled analysis of 2310 patients from four neoadjuvant clinical trials examined survival and treatment response in patients with HER2-low-positive (immunohistochemistry 1+ or 2+/in-situ hybridisa...
Prof Carsten Denkert et al | The Lancet Oncology
09.07.2021 | Added: 09.07.2021
Classifications: Breast Cancer Treatment
Keywords: HER2 Positive
menu_bookPublication menu_book
